Jump to page content

Search results

  • Press release Corona

    Why some people suffer more from COVID-19 than others

    A large number of people are currently contracting COVID-19. Fortunately, most of them are experiencing only mild symptoms, largely thanks to the high vaccination rate. However, in some individuals the disease takes a much more severe cause and our understanding about the underlying reasons is still insufficient. The human genome may hold a key to…

  • Press release Corona

    What happens in the lungs during SARS-CoV-2 infection

    A Berlin-based research group led by Charité - Universitätsmedizin Berlin has succeeded in simulating SARS-CoV-2 infection in human lungs and has gained important insights into the mechanism of infection. Using living lung samples, they were able to show that the virus is capable of directly infecting the cells of the human alveoli to only a very…

  • News Corona

    Why infection with the Omicron variant may cause less severe COVID-19 disease progression

    Observations from around the globe suggest that the Omicron variant of the SARS-CoV-2 coronavirus is much more infectious than its predecessor, Delta. But on the other hand, Omicron infections seem to cause milder disease: Hospital admissions and the number of deaths have increased only moderately compared to the huge rise in the number of cases.

  • Press release Corona

    The fatal role of T cells in COVID-19

    Scientists from the Berlin Institute of Health at Charité (BIH), together with colleagues from Charité – Universitätsmedizin Berlin and the university hospitals in Bonn and Aachen, have found a type of immune cells that is particularly active in severely ill COVID-19 patients. The CD16 positive T cells have an increased cytotoxic effect, especially…

  • Press release Corona

    Multicenter CATCOVID trial for treating severe COVID-19 progression enrolls first patient

    The clinical phase II trial CATCOVID initiated by the Berlin Institute of Health at Charité (BIH) has cleared the final regulatory hurdles with the receipt of a positive ethics committee vote and with approval from the Federal Institute for Drugs and Medical Devices (BfArM), enrolling its first patient this week at University of Leipzig Medical…

  • Press release Corona

    Are we prepared for the next pandemic? BIH and Tagesspiegel jointly hosted the Future Medicine Round Table in early November

    The SARS-CoV-2 coronavirus has had us in its grip for almost two years. Scientists have accomplished a great deal during this time: They have decoded the virus’s genome, developed tests and vaccines, and investigated how the virus takes hold in the body and spreads from person to person. Yet despite all this knowledge, the end is still not in…

  • Press release Corona

    The aftershock of the COVID-19 pandemic and genomic data for global human health: The BIH hosts panel discussions at the World Health Summit

    Although all the world has been focusing on vaccinations, infection rates and ICU occupancy levels, BIH scientists believe the real big wave is still coming: Long COVID. The patients who successfully survived COVID-19 but are still suffering from long-term effects will in all likelihood continue to present a challenge to the healthcare system for a…

  • Press release Digital Medicine

    Sylvia Thun is setting standards for medical data

    Professor Sylvia Thun is a physician, engineer, and expert in IT healthcare standards. The Director of the Core Unit eHealth and Interoperability at the Berlin Institute of Health at Charité (BIH) has now been awarded a lifetime W3 Professorship in Digital Medicine and Interoperability. Her aim is to better connect data from healthcare and…

Press contact

Dr. Stefanie Seltmann

Head of Communications, Press Spokesperson

Contact information
Phone:+49 30 450 543 019